Latest imidazoles Stories
LAKE FOREST, Ill., Oct. 30 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for Precedex(R), the company's innovative drug for in-hospital sedation. This approval allows for use of Precedex in non-intubated patients requiring sedation prior to and/or during surgical and other procedures. The additional indication complements Precedex's initial...
Olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque, researchers in Japan said. The trial was performed on 247 angina patients with native coronary artery lesions randomly assigned to receive 20 mg to 40mg/day of olmesartan or a placebo, and treated with a combination of beta-blockers, calcium channel blockers, diuretics, nitrates, glycemic control agents and/or statins per physician's guidance. Examinations were performed to assess...
Genta Incorporated (OTCBB: GNTA) announced the presentation of a progress update from the Company's ongoing Phase 3 trial of Genasense(R) (oblimersen sodium) Injection, Genta's lead oncology product, in patients with advanced melanoma. A pooled analysis of data from this study, which remains blinded, was compared with the Company's previous data from a similarly designed randomized trial. The comparative analysis shows that to date AGENDA has enrolled patients with similar demographics, and...
Barrier Therapeutics, Inc. (NASDAQ: BTRX) announced today the introduction of Xolegel CorePak(TM) for the treatment of seborrheic dermatitis. Now, patients with this chronic skin condition need only one prescription to get quick itch relief and to safely manage the overall condition long term. The two products in Xolegel CorePak are new Xebcort(TM) Gel, a 1% hydrocortisone gel, and Xolegel(R) (ketoconazole, USP) Gel, 2%. Xebcort Gel provides quick symptom relief and is presented as a 0.8...
The hypertension medication olmesartan medoxomil helps reverse the narrowing of the arteries in patients with high blood pressure, U.S. researchers said. Lead investigator Dr. Carlos M. Ferrario of Wake Forest University Baptist Medical Center in Winston-Salem, N.C., said the study evaluated the effects of an angiotensin receptor blocker -- olmesartan medoxomil -- versus a beta-blocker -- atenolol -- on vascular function and structure in patients with stage 1 hypertension. The study,...
NEW YORK (Reuters Health) - Zoledronic acid, used to inhibit the breakdown of bone and ward off the bone-thinning disease osteoporosis, could also be helpful to people with rheumatoid arthritis, researchers report. According to the results of a small proof-of-concept study, zoledronic acid -- also known as zoledronate or Aclasta -- increases the benefits seen when treating early rheumatoid arthritis with the standard drug, methotrexate. As reported in the medical journal Arthritis and...
By Gene EmeryBOSTON (Reuters) - Giving the anti-vomiting drug Zofran to children dehydrated by viral gastroenteritis helps them recover, but emergency room doctors may be overusing the quick-dissolving tablets, according to a study released on Wednesday.Over 1.5 million emergency room visits a year are due to childhood gastroenteritis. Doctors encourage dehydrated children admitted to emergency rooms with a "bug" to drink an electrolyte solution. But many are vomiting, so they can't...
